| __timestamp | Dynavax Technologies Corporation | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 4042025 |
| Thursday, January 1, 2015 | 22180000 | 5279557 |
| Friday, January 1, 2016 | 37257000 | 8073913 |
| Sunday, January 1, 2017 | 27367000 | 44864073 |
| Monday, January 1, 2018 | 64770000 | 53488904 |
| Tuesday, January 1, 2019 | 74986000 | 65896361 |
| Wednesday, January 1, 2020 | 79256000 | 69968267 |
| Friday, January 1, 2021 | 100156000 | 92047281 |
| Saturday, January 1, 2022 | 131408000 | 131819000 |
| Sunday, January 1, 2023 | 152946000 | 87501000 |
Unlocking the unknown
In the ever-evolving biotech industry, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent companies: Pharming Group N.V. and Dynavax Technologies Corporation, from 2014 to 2023.
Over the past decade, Dynavax Technologies has seen a significant increase in SG&A expenses, growing by approximately 760% from 2014 to 2023. This surge reflects the company's aggressive expansion and marketing strategies. In contrast, Pharming Group N.V. experienced a more moderate increase of around 2,070% during the same period, peaking in 2022.
By 2023, Dynavax's SG&A expenses were about 75% higher than Pharming's, indicating a more substantial investment in administrative and sales efforts. This trend highlights the differing strategic priorities of these companies, with Dynavax focusing more on scaling operations.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Cost Management Insights: SG&A Expenses for Blueprint Medicines Corporation and Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Corcept Therapeutics Incorporated
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and Dynavax Technologies Corporation
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Dynavax Technologies Corporation Trends and Insights
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Dynavax Technologies Corporation